Equities

Evaxion Biotech A/S

EVAX:NAQ

Evaxion Biotech A/S

Actions
  • Price (USD)3.95
  • Today's Change0.06 / 1.54%
  • Shares traded16.03k
  • 1 Year change-69.14%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

  • Revenue in USD (TTM)73.00k
  • Net income in USD-22.13m
  • Incorporated2008
  • Employees49.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
KALA BIO Inc0.00-42.20m19.74m43.00--2.58-----17.94-17.940.002.720.00----0.00-59.12-57.83-77.62-69.32--57.06---1,553.61---12.780.82---100.00--5.85---17.31--
Inhibitor Therapeutics Inc0.00-3.03m20.30m3.00--3.84-----0.0176-0.01760.000.03070.00----0.00-28.9227.48-30.9132.70------------0.000.00-----125.39------
CERo Therapeutics Holdings Inc0.00-2.54m20.32m8.00---------0.3796-0.37960.00-0.92260.00----0.00-9.96---33.80-----------------------279.82------
MEI Pharma Inc72.65m19.84m20.39m46.001.030.34271.010.28072.982.9810.908.930.6425--25.471,579,304.0017.55-25.3120.31-28.59----27.32-122.05----0.00--19.9597.5641.53------
Evaxion Biotech A/S - ADR73.00k-22.13m20.60m49.00------282.18-81.29-81.290.2665-1.250.0042--0.0911,489.80-126.74-100.11-183.85-131.65-----30,308.22-131,560.30---30.921.77------4.51--65.53--
AIM ImmunoTech Inc202.00k-28.96m20.60m26.00--2.08--101.98-0.595-0.5950.00420.20840.0068--0.14137,769.23-96.75-45.64-116.18-48.3579.21-231.75-14,337.62-11,695.01----0.00--43.26-11.26-48.94--35.73--
Serina Therapeutics Inc142.00k-14.80m20.76m4.00--1.64--146.17-13.72-13.720.13165.070.0187--4.6635,500.00-194.80-194.46----71.8385.80-10,430.28-2,347.36---2.030.4489--317.65-36.69-41.49------
Alaunos Therapeutics Inc5.00k-35.14m20.82m1.00--3.30--4,163.25-2.20-2.200.00030.39390.0001--2.005,000.00-96.01-74.83-149.28-89.57-----702,800.00-10,508.06---14.830.00---99.83-49.086.86---15.56--
Eom Pharmaceutical Holdings Inc0.00-4.93m20.84m3.00---------0.0435-0.04350.00-0.0212------0.00---126.34---171.37------------7.41-------254.37------
Biomx Inc0.00-26.17m21.20m58.00--5.73-----0.5433-0.54330.000.0670.00----0.00-74.18---101.74-------------21.950.7841------7.59------
Synlogic Inc3.37m-57.28m21.43m6.00--0.3963--6.36-11.41-11.410.65814.640.0362----561,833.30-61.46-40.57-74.45-43.82-----1,699.26-3,245.93----0.00009--185.685.9913.40---48.05--
Flora Growth Corp76.07m-47.36m21.67m97.00--2.36--0.2848-6.62-7.9710.040.71671.456.7631.13784,237.10-89.22---130.91--23.32---61.35--0.7897--0.2317--127.75---1.87------
TherapeuticsMD Inc1.30m-7.70m21.68m1.00--0.7403--16.65-0.7466-1.000.12492.540.0195----1,302,000.00-11.51-53.35-19.23-111.61100.0086.67-591.32-236.57----0.00---98.14-39.53-816.85------
OncoCyte Corp1.50m-25.80m22.01m43.00--1.07--14.64-3.08-3.470.18693.100.0172--1.2034,953.49-28.41-35.11-31.93-39.7127.48---1,653.69-2,373.36---146.070.00--56.89---34.84--55.41--
NRX Pharmaceuticals Inc0.00-30.16m22.02m2.00---------2.95-2.950.00-0.13980.00-------182.00-120.57---168.40--------------------24.14------
Data as of May 03 2024. Currency figures normalised to Evaxion Biotech A/S's reporting currency: US Dollar USD

Institutional shareholders

0.91%Per cent of shares held by top holders
HolderShares% Held
LM Advisors LLCas of 31 Dec 202333.73k0.70%
Beacon Capital Management LLC (Tennessee)as of 31 Dec 20234.86k0.10%
Citadel Securities LLCas of 31 Dec 20232.46k0.05%
Renaissance Technologies LLCas of 31 Dec 20231.40k0.03%
JPMorgan Securities LLC (Investment Management)as of 31 Dec 2023900.000.02%
RhumbLine Advisers LPas of 31 Dec 2023291.000.01%
Group One Trading LPas of 31 Dec 202339.000.00%
UBS Securities LLCas of 31 Dec 202328.000.00%
Two Sigma Securities LLCas of 31 Dec 20230.000.00%
Morgan Stanley & Co. LLCas of 31 Dec 20230.000.00%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.